Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.3 CHF | +0.12% | -1.10% | +14.16% |
04-09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
04-04 | Stocks Close in Green as Swiss Inflation Unexpectedly Slows | MT |
Sales 2024 * | 182M 199M 15.92B | Sales 2025 * | 206M 225M 18.01B | Capitalization | 484M 529M 42.37B |
---|---|---|---|---|---|
Net income 2024 * | 23M 25.15M 2.01B | Net income 2025 * | 35M 38.27M 3.07B | EV / Sales 2024 * | 2.98 x |
Net Debt 2024 * | 57.88M 63.29M 5.07B | Net Debt 2025 * | 12.51M 13.68M 1.1B | EV / Sales 2025 * | 2.41 x |
P/E ratio 2024 * |
20.2
x | P/E ratio 2025 * |
17
x | Employees | 147 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.55% |
Latest transcript on Basilea Pharmaceutica AG
1 day | +0.12% | ||
1 week | -1.10% | ||
Current month | +7.04% | ||
1 month | +7.47% | ||
3 months | +16.81% | ||
6 months | +10.26% | ||
Current year | +14.16% |
Managers | Title | Age | Since |
---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 59 | 31/08/14 |
Adesh Kaul
DFI | Director of Finance/CFO | 50 | 31/12/08 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 60 | 30/04/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nicole Onetto
BRD | Director/Board Member | 71 | 26/04/17 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 31/12/21 |
Director/Board Member | 69 | 08/04/13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 773 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 40.3 | +0.12% | 15,654 |
25/04/24 | 40.25 | -0.74% | 22,275 |
24/04/24 | 40.55 | -1.70% | 34,286 |
23/04/24 | 41.25 | +0.86% | 43,839 |
22/04/24 | 40.9 | +0.37% | 37,920 |
Delayed Quote Swiss Exchange, April 26, 2024 at 04:31 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.16% | 529M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BSLN Stock